Diurnal Group
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United KingdomWebsite
www.diurnal.comRevenue
<$5 MillionIndustry
About Diurnal Group
Is Diurnal Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Diurnal Group
Earning: See what the market has to say on Diurnal Group recently announced quarterly report
Diurnal Group, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Diurnal Group has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Diurnal Group has new funding data
Product Launch: Get notified when Diurnal Group launches new products
Click to see if Diurnal Group had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Diurnal Group is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Diurnal Group
Find more new buyers
Compare Similar Companies to Diurnal Group
Compare insights from companies similar to Diurnal Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Diurnal Group
Diurnal Group Tech Stack
A closer look at the technologies used by Diurnal Group
Most Recent Scoops
Diurnal Group News & Media
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Diurnal Group
Diurnal is a European, UK-headquartered specialty pharmaceutical company focused on developing lifelong treatments for rare and chronic endocrine conditions. Their global presence caters to UK residents, non-UK residents, investors, and media relations. Diurnal Limited is registered in England and Wales, with a commitment to advancing hormone thera... Read More